MSK Nassau — Uniondale, New York

MSK Nassau is a clinical research site located in Uniondale, New York, United States 11553.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

MSK Nassau has participated in 11 clinical trials with 7 currently active.

Therapeutic areas: Multiple Myeloma, Advanced Malignancies, NSCLC.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Nassau?

MSK Nassau has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Nassau conducted?

MSK Nassau has 11 clinical trials on record, with 7 currently active. Their work covers Multiple Myeloma, Advanced Malignancies, NSCLC.

Is MSK Nassau accredited by Crixeo Health?

Yes — MSK Nassau holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about MSK Nassau?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.